| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.28 | 0.06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.49 | 0.07 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |